MeVC27 (L), n=3 cell(s)

Main group: Visual Centrifugal Neurons; Neurotransmitter consensus prediction: unclear

Mean synapse counts per layer

  LA
Post -
Pre -
  M1 M2 M3 M4 M5 M6 M7 M8 M9 M10 Total
0 - - - - - 115.7 225.3 15.3 1.0 - 357.3
1 - - - - - 95.3 362.7 27.3 2.0 - 487.3
  LO1 LO2 LO3 LO4 LO5a LO5b LO6 Total
Post - - - - - - - -
Pre - - - - - - - -
  AME
0 -
1 -
  LOP1 LOP2 LOP3 LOP4 Total
Post - - - - -
Pre - - - - -
  central brain
0 352.7
1 32.3

Neuron visualizations

Population spatial coverage

Medulla

Number of post synapses:1072
Number of pre synapses:1462
Number of output connections:2880
Coverage factor:1.7
Columnar completeness:0.48
Area completeness:0.60
Cell size (columns):248

Lobula

Number of post synapses:0
Number of pre synapses:0
Number of output connections:0
Coverage factor:0
Columnar completeness:0
Area completeness:0
Cell size (columns):0

Lobula Plate

Number of post synapses:0
Number of pre synapses:0
Number of output connections:0
Coverage factor:0
Columnar completeness:0
Area completeness:0
Cell size (columns):0

Optic Lobe Connectivity

Inputs

  instance NT total connections connections /#MeVC27 (L) % % cumu.
0 MeVP12 (R) ACh 250 83.3 23.8% 23.8%
1 Tm34 (R) Glu 151 50.3 14.4% 38.2%
2 aMe26 (R) ACh 146 48.7 13.9% 52.1%
3 MeVC3 (L) ACh 81 27.0 7.7% 59.8%
4 Cm9 (R) Glu 54 18.0 5.1% 65.0%
5 MeVP1 (R) ACh 38 12.7 3.6% 68.6%
6 MeVC8 (L) ACh 18 6.0 1.7% 70.3%
7 Cm4 (R) Glu 15 5.0 1.4% 71.7%
8 Cm3 (R) GABA 14 4.7 1.3% 73.0%
9 MeLo3b (R) ACh 14 4.7 1.3% 74.4%
10 MeTu4a (R) ACh 14 4.7 1.3% 75.7%
11 MeLo6 (R) ACh 13 4.3 1.2% 77.0%
12 MeVP14 (R) ACh 12 4.0 1.1% 78.1%
13 Mi10 (R) ACh 10 3.3 1.0% 79.0%
14 OA-AL2i4 (R) OA 10 3.3 1.0% 80.0%
15 MeLo5 (R) ACh 8 2.7 0.8% 80.8%
16 MeVC21 (R) Glu 8 2.7 0.8% 81.5%
17 MeVC27 (L) unclear 8 2.7 0.8% 82.3%
18 MeVP62 (R) ACh 8 2.7 0.8% 83.0%
19 Cm16 (R) Glu 7 2.3 0.7% 83.7%
20 Cm8 (R) GABA 7 2.3 0.7% 84.4%
21 Dm2 (R) ACh 7 2.3 0.7% 85.0%
22 MeVC20 (R) Glu 7 2.3 0.7% 85.7%
23 aMe17a (R) Glu 6 2.0 0.6% 86.3%
24 Cm5 (R) GABA 6 2.0 0.6% 86.9%
25 MeTu1 (R) ACh 5 1.7 0.5% 87.3%
26 Mi15 (R) ACh 5 1.7 0.5% 87.8%
27 Mi17 (R) GABA 5 1.7 0.5% 88.3%
28 Cm25 (R) Glu 4 1.3 0.4% 88.7%
29 Cm27 (R) Glu 4 1.3 0.4% 89.0%
30 Cm28 (R) unclear 4 1.3 0.4% 89.4%
31 MeTu3b (R) ACh 4 1.3 0.4% 89.8%
32 MeTu3c (R) ACh 4 1.3 0.4% 90.2%
33 MeVP15 (R) ACh 4 1.3 0.4% 90.6%
34 MeVP57 (R) unclear 4 1.3 0.4% 91.0%
35 MeVP6 (R) Glu 4 1.3 0.4% 91.3%
36 Tm37 (R) Glu 4 1.3 0.4% 91.7%
37 5-HTPMPV03 (L) 5HT 3 1.0 0.3% 92.0%
38 Cm12 (R) GABA 3 1.0 0.3% 92.3%
39 Cm21 (R) GABA 3 1.0 0.3% 92.6%
40 Cm31b (R) GABA 3 1.0 0.3% 92.9%
41 Cm6 (R) GABA 3 1.0 0.3% 93.1%
42 MeTu4c (R) ACh 3 1.0 0.3% 93.4%
43 MeVC24 (R) Glu 3 1.0 0.3% 93.7%
44 MeVP32 (R) ACh 3 1.0 0.3% 94.0%
45 MeVP45 (R) ACh 3 1.0 0.3% 94.3%
46 MeVPMe12 (R) ACh 3 1.0 0.3% 94.6%

Outputs

  instance NT total connections connections /#MeVC27 (L) % % cumu.
0 Cm5 (R) GABA 249 83.0 8.6% 8.6%
1 Cm3 (R) GABA 228 76.0 7.9% 16.5%
2 Cm8 (R) GABA 161 53.7 5.6% 22.1%
3 MeVC21 (R) Glu 121 40.3 4.2% 26.3%
4 MeTu4c (R) ACh 112 37.3 3.9% 30.2%
5 Tm34 (R) Glu 104 34.7 3.6% 33.8%
6 Cm6 (R) GABA 91 30.3 3.2% 37.0%
7 MeTu4a (R) ACh 74 24.7 2.6% 39.5%
8 MeVP58 (R) unclear 72 24.0 2.5% 42.0%
9 OA-AL2i4 (R) OA 64 21.3 2.2% 44.2%
10 Cm28 (R) unclear 55 18.3 1.9% 46.2%
11 MeLo6 (R) ACh 55 18.3 1.9% 48.1%
12 MeLo5 (R) ACh 54 18.0 1.9% 49.9%
13 Cm13 (R) Glu 52 17.3 1.8% 51.7%
14 Cm18 (R) Glu 50 16.7 1.7% 53.5%
15 Cm27 (R) Glu 48 16.0 1.7% 55.1%
16 MeVC20 (R) Glu 48 16.0 1.7% 56.8%
17 Cm4 (R) Glu 46 15.3 1.6% 58.4%
18 MeVP62 (R) ACh 43 14.3 1.5% 59.9%
19 MeVP6 (R) Glu 39 13.0 1.4% 61.2%
20 Mi17 (R) GABA 39 13.0 1.4% 62.6%
21 MeLo3b (R) ACh 38 12.7 1.3% 63.9%
22 Cm7 (R) Glu 36 12.0 1.2% 65.2%
23 MeVP12 (R) ACh 36 12.0 1.2% 66.4%
24 TmY10 (R) ACh 36 12.0 1.2% 67.6%
25 MeTu4e (R) ACh 32 10.7 1.1% 68.8%
26 Tm37 (R) Glu 32 10.7 1.1% 69.9%
27 Cm9 (R) Glu 31 10.3 1.1% 70.9%
28 MeVP14 (R) ACh 29 9.7 1.0% 71.9%
29 MeVP61 (R) unclear 27 9.0 0.9% 72.9%
30 Dm2 (R) ACh 26 8.7 0.9% 73.8%
31 Cm16 (R) Glu 24 8.0 0.8% 74.6%
32 aMe17a (R) Glu 22 7.3 0.8% 75.4%
33 MeTu1 (R) ACh 20 6.7 0.7% 76.1%
34 Tm35 (R) Glu 20 6.7 0.7% 76.8%
35 aMe9 (R) ACh 19 6.3 0.7% 77.4%
36 MeVC3 (L) ACh 19 6.3 0.7% 78.1%
37 Mi16 (R) GABA 18 6.0 0.6% 78.7%
38 MeVP1 (R) ACh 16 5.3 0.6% 79.3%
39 Tm5c (R) Glu 16 5.3 0.6% 79.8%
40 Cm12 (R) GABA 15 5.0 0.5% 80.3%
41 Cm24 (R) Glu 15 5.0 0.5% 80.9%
42 Cm25 (R) Glu 15 5.0 0.5% 81.4%
43 MeVP29 (R) ACh 15 5.0 0.5% 81.9%
44 Cm23 (R) Glu 14 4.7 0.5% 82.4%
45 MeVPMe12 (R) ACh 14 4.7 0.5% 82.9%
46 Pm4 (R) GABA 14 4.7 0.5% 83.4%
47 aMe26 (R) ACh 13 4.3 0.5% 83.8%
48 MeTu3b (R) ACh 13 4.3 0.5% 84.3%
49 MeVP11 (R) ACh 13 4.3 0.5% 84.7%
50 Cm21 (R) GABA 12 4.0 0.4% 85.1%
51 Cm31b (R) GABA 12 4.0 0.4% 85.5%
52 Tm38 (R) ACh 12 4.0 0.4% 86.0%
53 Mi10 (R) ACh 11 3.7 0.4% 86.3%
54 Cm19 (R) GABA 10 3.3 0.3% 86.7%
55 Tm16 (R) ACh 10 3.3 0.3% 87.0%
56 MeLo1 (R) ACh 9 3.0 0.3% 87.3%
57 MeVPLo1 (R) Glu 9 3.0 0.3% 87.7%
58 Mi19 (R) 5HT 9 3.0 0.3% 88.0%
59 Pm12 (R) Glu 9 3.0 0.3% 88.3%
60 TmY18 (R) ACh 9 3.0 0.3% 88.6%
61 aMe17e (R) Glu 8 2.7 0.3% 88.9%
62 Cm20 (R) GABA 8 2.7 0.3% 89.1%
63 MeVC27 (L) unclear 8 2.7 0.3% 89.4%
64 MeVP15 (R) ACh 8 2.7 0.3% 89.7%
65 MeVP20 (R) unclear 8 2.7 0.3% 90.0%
66 Mi15 (R) ACh 8 2.7 0.3% 90.3%
67 Mi4 (R) GABA 8 2.7 0.3% 90.5%
68 TmY17 (R) ACh 8 2.7 0.3% 90.8%
69 Lat3 (R) unclear 7 2.3 0.2% 91.1%
70 MeVC_unclear (R) Glu 7 2.3 0.2% 91.3%
71 Pm13 (R) Glu 7 2.3 0.2% 91.5%
72 Cm10 (R) GABA 6 2.0 0.2% 91.7%
73 MeTu3c (R) ACh 6 2.0 0.2% 92.0%
74 MeVC8 (L) ACh 6 2.0 0.2% 92.2%
75 Mi18 (R) GABA 6 2.0 0.2% 92.4%
76 Cm14 (R) GABA 5 1.7 0.2% 92.5%
77 MeVC24 (R) Glu 5 1.7 0.2% 92.7%
78 MeVP32 (R) ACh 5 1.7 0.2% 92.9%
79 MeVP34 (R) unclear 5 1.7 0.2% 93.1%
80 MeVPMe5 (R) Glu 5 1.7 0.2% 93.2%
81 Tm20 (R) ACh 5 1.7 0.2% 93.4%
82 Tm4 (R) ACh 5 1.7 0.2% 93.6%
83 TmY9b (R) ACh 5 1.7 0.2% 93.8%
84 5-HTPMPV03 (L) 5HT 4 1.3 0.1% 93.9%
85 Cm11c (R) ACh 4 1.3 0.1% 94.0%
86 Cm22 (R) GABA 4 1.3 0.1% 94.2%
87 Cm30 (R) GABA 4 1.3 0.1% 94.3%
88 Dm-DRA1 (R) Glu 4 1.3 0.1% 94.5%
89 ME_unclear (R) ACh 4 1.3 0.1% 94.6%
90 MeVC2 (L) ACh 4 1.3 0.1% 94.7%
91 MeVP22 (R) GABA 4 1.3 0.1% 94.9%
92 MeVP46 (R) Glu 4 1.3 0.1% 95.0%
93 MeVPMe5 (L) Glu 4 1.3 0.1% 95.1%
94 MeVPMe8 (R) Glu 4 1.3 0.1% 95.3%
95 Mi2 (R) Glu 4 1.3 0.1% 95.4%
96 Tm29 (R) Glu 4 1.3 0.1% 95.6%
97 Tm32 (R) Glu 4 1.3 0.1% 95.7%
98 5-HTPMPV03 (R) 5HT 3 1.0 0.1% 95.8%
99 Cm34 (R) Glu 3 1.0 0.1% 95.9%
100 MeVC7a (L) ACh 3 1.0 0.1% 96.0%
101 T2a (R) ACh 3 1.0 0.1% 96.1%
102 Tm2 (R) ACh 3 1.0 0.1% 96.2%
103 Tm3 (R) ACh 3 1.0 0.1% 96.3%
104 Tm31 (R) Glu 3 1.0 0.1% 96.4%
105 Tm5Y (R) ACh 3 1.0 0.1% 96.5%
106 TmY9a (R) ACh 3 1.0 0.1% 96.6%